search
Drug Topics
Trends
- 1Survey: Patient Support Key to GLP-1 Telehealth Success▼New U.S. News & World Report Survey Highlights How Patient Priorities and Ongoing Support Drive GLP-1 Telehealth Success
U.S. News & World Report has released a new survey examining what makes GLP-1 telehealth programs work, finding that patient priorities and ongoing support are central drivers of success. The findings point to sustained coaching and follow-up care, rather than medication access alone, as decisive factors for people using telehealth services for weight-loss drugs.
- 2BostonGene to Present AI Platform at ESMO Congress 2026▼BostonGene Showcases Biologically Grounded AI at ESMO Congress 2026 to Advance Drug Development and Precision Clinical Decision-Making
BostonGene announced it will showcase its biologically grounded AI platform at the ESMO Congress 2026, positioning the technology as a tool for advancing drug development and precision clinical decision-making in oncology. The company says its approach integrates biological context into AI models to support more accurate, patient-specific treatment insights for researchers and clinicians.
- 3Podcast explores 'cuckooing' and a friendship nearly destroyed●A tale of two trap houses: being cuckooed ruined my friend’s life – but did it then help save him? – podcast By Written
A Guardian podcast episode tells the story of a man whose life was ruined when drug gangs took over his home in Britain, a practice known as cuckooing, and asks whether the ordeal ultimately helped save him. Written by Max Daly and read by Simon Darwen, the episode examines how county lines gangs have moved off the streets and into victims' homes.
- 4CHEST investigations look at COPD care, ensifentrine and AI education▼CHEST Investigations Explore COPD Guideline Adherence, Adding Ensifentrine, and Use of AI in Education
New CHEST investigations examine three topics in respiratory medicine: how well clinicians adhere to COPD treatment guidelines, the role of ensifentrine as an added therapy for the disease, and the use of artificial intelligence in medical education. The coverage highlights ongoing efforts to improve COPD management and to integrate new drug options and AI tools into clinical practice and training.
- 5
Obesity medications are a leading health news topic today, with coverage focusing on the growing use of weight-loss drugs such as GLP-1 treatments. Reports highlight rising demand, questions about long-term safety and access, and debate over whether these drugs should reshape how obesity is treated worldwide.
- 6
The US Food and Drug Administration has approved a new medicine for weight loss, according to reports from international outlets including Polish Radio and Olhar Digital. Details about the drug's name, manufacturer and trial results were not specified in the available coverage. The decision adds to a fast-growing market of obesity treatments that has drawn global attention from patients, doctors and pharmaceutical companies.